抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
U-104，99% | C13H12FN3O3S | |||
|
|
|||||
|
BAY-876，98% | C24H16F4N6O2 | |||
|
|
|||||
|
NCT-501，98% | C21H32N6O3 | |||
|
|
|||||
|
Lomitapide，99% | C39H37F6N3O2 | |||
|
|
|||||
|
6-METHYLAMINOPURINE 9-RIBOFURANOSIDE，98% | C11H15N5O4 | |||
|
|
|||||
|
OSELTAMIVIR ACID，98% | C14H24N2O4 | |||
|
|
|||||
|
Tipifarnib，98% | C27H22Cl2N4O | |||
|
|
|||||
|
RO 61-8048，99% | C17H15N3O6S2 | |||
|
|
|||||
|
甲磺酸洛美他派，≥98% | C40H41F6N3O5S | |||
|
|
|||||
|
AZD7545，99% | C19H18ClF3N2O5S | |||
|
|
|||||
|
SR3335，98% | C13H9F6NO3S2 | |||
|
|
|||||
|
BPTES，95%(HPLC) | C24H24N6O2S3 | |||
|
|
|||||
|
|
UK 383367,BMP-1（PCP）抑制劑，98% | C15H24N4O4 | |||
|
|
|||||
|
SW033291，98% | C21H20N2OS3 | |||
|
|
|||||
|
Eliglustat，98% | C23H36N2O4 | |||
|
|
|||||
|
噻克索酮，≥98% | C7H4O3S | |||
|
|
|||||
|
Sulfaphenazole，99% | C15H14N4O2S | |||
|
|
|||||
|
Norgestimate metabolite Norelgestromin (異構體混合物)，≥98% | C21H29NO2 | |||
|
|
|||||
|
Isovaleramide，98% | C5H11NO | |||
|
|
|||||
|
Malotilate，99%(GC) | C12H16O4S2 | |||
|
|
|||||
|
(S)-(-)-4-Bromotetramisole Oxalate，98% | C13H13BrN2O4S | |||
|
|
|||||
|
Halobetasol Propionate，98% | C25H31ClF2O5 | |||
|
|
|||||
|
GW4869，96% | C30H30Cl2N6O2 | |||
|
|
|||||
